Organogenesis Holdings Inc. provided earnings guidance for the first quarter and for the year ending December 31, 2024. For modeling purposes, the company expects first quarter revenue in the range of approximately $98 million to $104 million.

The Company expects Net revenue between $445.0 million and $470.0 million, an increase of approximately 3% to 9% year-over-year, as compared to net revenue of $433.1 million for the year ended December 31, 2023. Net income (loss) between ($10.6) million and $4.6 million and adjusted net income (loss) between ($8.1) million and $7.1 million.